SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares

Published on 5 Jan 2024 on GuruFocus.com via Yahoo Finance

SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares

On January 2, 2024, Davis Timothy E JR, a Director at SI-BONE Inc (NASDAQ:SIBN), completed the sale of 9,900 shares of the company. The transaction was filed with the SEC and can be found through this SEC Filing.

Warning! GuruFocus has detected 3 Warning Signs with SIBN.

SI-BONE Inc is a medical device company that focuses on the design, development, and commercialization of musculoskeletal devices for patients with spine disorders. The company's flagship product, the iFuse Implant System, is used in minimally invasive surgery to treat sacroiliac joint dysfunction.

Read the rest of the article

NASDAQ.SIBN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

News

SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares

NASDAQ.SIBN price evolution

Want to become a better investor?

SI-BONE (NASDAQ:SIBN) shareholders have endured a 20% loss from investing in the...

SI-BONE, Inc. (NASDAQ:SIBN) Just Released Its Third-Quarter Earnings: Here's...

SI-BONE Inc (SIBN) Q3 2024 Earnings Report Preview: What To Look For

SI-BONE, Inc. (NASDAQ:SIBN) Q1 2024 Earnings Call Transcript

Here's What Analysts Are Forecasting For SI-BONE, Inc. (NASDAQ:SIBN) After Its First-Quarter Results

When Will SI-BONE, Inc. (NASDAQ:SIBN) Become Profitable?

SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares

Insider Sell: President, Commercial Ops Anthony Recupero Sells 8,457 Shares of SI-BONE Inc (SIBN)

The past three years for SI-BONE (NASDAQ:SIBN) investors has not been profitable

Has SiBone (SIBN) Outpaced Other Medical Stocks This Year?